Spermidine (SPD) is an endogenous aliphatic amine that modulates GluN2B-containing NMDA receptors and improves memory. Recent evidence suggests that systemic SPD improves the persistence of the long term memory of fear. However, the role of hippocampal polyamines and its binding sites in the persistence of fear memory is to be determined, as well as its putative underlying mechanisms. This study investigated whether the intrahippocampal (i.h.) infusion of spermidine or arcaine, modulators of polyamine binding site at GluN2B-containing NMDA receptors, alters the persistence of the memory of contextual fear conditioning task in rats. We also investigated whether protein synthesis and cAMP dependent protein kinase (PKA) play a role in SPD-induced improvement of the fear memory persistence. While 12 h post-training infusion of spermidine facilitated, arcaine and the inhibitor of protein synthesis (anisomycin) impaired the memory of fear assessed 7 days after training. The infusion of arcaine, anisomycin or a selective PKA inhibitor (H-89), at doses that have no effect on memory per se, prevented the SPD-induced improvement of memory persistence. H-89 prevented the stimulatory effect of SPD on phospho-PKA/total-PKA ratio. These results suggests that the improvement of fear memory persistence induced by spermidine involves GluN2B-containing NMDA receptors, PKA pathway and protein synthesis in rats.
Introduction
The persistence of long-term fear memory (LTM) is a delayed consolidation process that requires activation of several molecules and synthesis of new proteins around the time 12-24 h posttraining (Katche, Cammarota, & Medina, 2013; Parfitt, Barbosa, Campos, Koth, & Barros, 2012) . Accordingly, phosphorylation of mitogen activated kinases (MAPKs), extracellular signal-regulated kinase (ERK), increased synthesis of transcription factors Zif268 and c-fos (Bekinschtein et al., 2007 (Bekinschtein et al., , 2008 and circadian oscillation of the hippocampal cAMP/MAPK/CREB transcriptional pathway (Eckel-Mahan et al., 2008) seem to be necessary for memory persistence. In addition, behavioral evidence suggests that the activation of cAMP dependent protein kinase (PKA) in the hippocampus is critical for the persistence of fear memory (Rossato, Bevilaqua, Izquierdo, Medina, & Cammarota, 2009 ) and persistence of extinction of LTM (Chai et al., 2014) , since both are impaired by the respective administration of the PKA inhibitors, PKI and RpcAMPS, twelve hours after training. Disruption of this late-phase process leads to memory loss at 7 days but not 2 days after learning (Bekinschtein et al., 2007; Katche et al., 2010) .
The polyamines putrescine, spermine (SPM) and spermidine (SPD) are a group of aliphatic amines that are present at high concentrations in cerebral structures (Carter, 1994) . SPM and SPD are synthesized in neurons (Bernstein & Muller, 1999; Krauss, Weiss, Langnaese, & Richter, 2007) and accumulate in synaptic vesicles, reaching concentrations between 1.5 and 2.8 mM (Masuko et al., 2003) . Immunocytochemical studies have revealed a highly diverse SPD/SPM-like immunoreactivity in neurons of the rat brain (Laube, Bernstein, Wolf, & Veh, 2002) , with an intense labeling of neuropil in selected areas, such as the molecular layer of the dentate gyrus and basolateral amygdaloid nucleus, which also presents strong immunoreactivity in neurons (Laube et al., 2002) . Glial cells rapidly and efficiently uptake and accumulate SPM and SPD in hippocampus, cerebral cortex, cerebellum (Laube & Veh, 1997) and in retina (Biedermann, Skatchkov, Bringmann, & Pannicke, 1999; Skatchkov, Woodbury-Fariña, & Eaton, 2014; Skatchkov et al., 2000) , probably by organic cation transporters SLC22A1, 2, 3, (Dot, Lluch, Blanco, & Rodríguez-Alvarez, 2000; Kucheryavykh et al., 2012 Kucheryavykh et al., , 2014 SalaRabanal et al., 2013) and SLC18B1 (Hiasa et al., 2014) expressed in glial cells. In astrocytes, polyamines promote glial intercellular communication by interacting with glial Cx43 gap junctions (Benedikt et al., 2012; Skatchkov et al., 2014) . This occurs because polyamines remove hydrogen block of Cx43 gap junctions (Skatchkov, Bukauskas, Benedikt, Inyushin, & Kucheryavykh, 2015) , allowing their opening and astrocyte-to-astrocyte molecular transfer. In addition, glia may control SPD stores and further control the use of this polyamine . Interestingly, PKA stimulation decreases the activity of SLC22A2, an organic cation transporter that has low affinity for SPD (SalaRabanal et al., 2013) , in HEK-293 cells (Cetinkaya et al., 2003) .
SPD is a positive modulator of the NMDA receptor that selectively activates NMDA receptors containing the GluN2B subunit (Mony, Zhu, Carvalho, & Paoletti, 2011) . Accumulating evidence suggests that polyamines modulate learning and memory (Kishi, Ohno, & Watanabe, 1998; Rubin et al., 2000 Rubin et al., , 2001 Rubin et al., , 2004 . Accordingly, systemic (Camera, Mello, Ceretta, & Rubin, 2007; Ceretta, Camera, Mello, & Rubin, 2008; Frühauf et al., 2015; Ribeiro, Signor, Mello, & Rubin, 2013) , intrahippocampal (i.h.) (Berlese et al., 2005; Guerra et al., 2006) and intra-amygdalar (Rubin et al., 2001 (Rubin et al., , 2004 administration of SPD or spermine improve the memory of different tasks in rats and mice. Interestingly, SPD-induced facilitation of consolidation of memory involves the sequential activation of PKC and PKA/CREB signaling in the hippocampus of rats (Guerra et al., 2011 (Guerra et al., , 2012 . At last, it has been recently shown that delayed systemic administration (12 h after training) of SPD facilitates and arcaine, an antagonist of the polyamine binding site at the NMDA receptor, impairs the persistence of fear memory (Signor, Mello, Porto, Ribeiro, & Rubin, 2014) .
Despite recent evidence suggesting a facilitatory effect for systemically administered polyamines on the persistence of fear memory and the involvement of PKA activation in memory consolidation, it remains to be addressed whether the i.h. infusion of polyamines alter the persistence of fear memory by PKAmediated mechanisms. Therefore, in the current study we investigated whether the i.h. infusion of SPD and arcaine alter the persistence of memory in rats. We also investigated whether protein synthesis and PKA are involved in the facilitatory effect of SPD on memory persistence.
Materials and methods

Animals
Experimentally naive male adults Wistar rats (220-280 g), from the animal house of the Federal University of Santa Maria were used. The animals were housed four to a cage and maintained on a 12 h light/dark cycle (lights on at 7:00 A.M.) at a temperature of 21°C with water and standard laboratory chow (Guabi, Santa Maria, Rio Grande do Sul, Brazil) ad libitum. All experimental procedures were conducted in accordance with the policies on the use of animals and humans in neuroscience research, revised and approved by the Society for Neuroscience Research in January 1995 and with the institutional and national regulations for animal research (process 068/2011).
Surgery
Rats were anaesthetized with ketamine (80 mg/kg, i.p.) and xylazine (8 mg/kg, i.p.), and were implanted with two 27-gauge guide cannulae placed 1 mm above the CA1 region of the dorsal hippocampus at the following coordinates: A = 4.0 mm; L = 3.0 mm; and V = 2.0 mm (Paxinos & Watson, 1986) . Placement of injections was histologically verified, as described elsewhere (Rubin et al., 1997) . Only data from the animals with correct cannulae placement were analyzed (Fig. 1C) .
Drugs and injections
Animals were injected with saline (0.9% NaCl), N-(3-aminopropyl)-1.4-butanediamine trihydrochloride (SPD; Sigma, St. Louis, MO), 1,4-diguanidinobutane sulfate (arcaine; Pfaltz & Bauer, Waterbury, CT, USA), anisomycin (Sigma, St. Louis, MO) or N-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride (H-89; Sigma St. Louis, MO). SPD and arcaine were dissolved in saline. Anisomycin was dissolved in 1 M HCl, diluted in PBS, the pH was adjusted to 7.2 with NaOH. H-89 was dissolved in 0.01% DMSO in 50 mM PBS (pH 7.4). Infusions were performed 11:30 or 12 h post-training bilaterally into the hippocampus (0.5 ll/brain hemisphere for 1 min). The injections were performed by using an infusion pump using a 30-gauge needle fitted into the guide cannula. The tip of the infusion needle protruded 1.0 mm beyond that of the guide cannula into the CA1 region in the dorsal hippocampus. The needles were left in place for additional 60 s to minimize backflow.
Apparatus
Contextual fear training and testing took place in an identical observation chamber (30 Â 25 Â 25 cm), located in a well-lit room. The front and ceiling walls of the chamber were made of clear acrylic plastic, whereas the lateral and rear walls were made of opaque plastic. The floor of the chamber consisted of 32 stainless steel rods (3 mm diameter), spaced 1 cm apart and wired to a shock generator. The cage was cleaned with 30% ethyl alcohol before and after each rat occupied it.
Contextual fear conditioning
Each animal was subjected to a single fear-conditioning training session, as described by Rubin et al. (2004) with some modifications. In brief, the rat was placed in the conditioning chamber (conditioned stimulus, CS) and habituated to the apparatus for 3 min. Immediately after habituation, three 1 s, 0.4 mA foot shocks (unconditioned stimulus, US) were delivered. The shocks were 40 s apart. After the last US, rats were allowed to stay in the chamber for additional 60 s before returning to their home cages.
Two or seven days after training, each rat was placed back in the conditioning chamber and an 8 min test session was performed. During this time no shock was given and, every 4 s, an instantaneous observation of the rat was made to assess whether it was in freezing, or not. Behavior was judged as freezing if there was an absence of any visible movement, except for that required for breathing. The percentage of samples scored as freezing during this 8 min was taken as a contextual fear conditioning measure.
Preparation of tissues and Western blot analysis
Western blot analysis was carried out as described previously (Casu et al., 2007) with minor modifications. Hippocampi from rat were homogenized on ice in a lyses buffer containing (in mM) 10 HEPES (pH 7.9), 10 KCl, 2 MgCl 2 , 1 EDTA, 1 NaF, 1 phenylmethanesulphonyl fluoride, 10 b-glycerophosphate, 1 DTT and 2 sodium orthovanadate, and mixture of protease and phosphatase inhibitors (Sigma, St. Louis, MO). The homogenates were (12.700g for 30 min at 4°C) and the supernatant (S1) was denominated cytosolic fraction. Protein concentration in the cytosolic fraction was measured by bicinchonic acid assay (BCA) using bovine serum albumin as standard. The supernatant (20 lg protein each) was resolved by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted onto nitrocellulose membranes (Millipore). Membranes were blocked with 2.5% albumin plus 2.5% non-fat milkin TBS-T (1% Tween 20 in Tris-borate saline) at room temperature for 1 h, then incubated overnight at 4°C with primary antibody rabbit anti-PKA (1:10,000, Santa Cruz Biotechnology). Primary antibody rabbit antiphosphoPKA (1:5000, Santa Cruz Biotechnology) was blocked only with 5% bovine serum albumin. This procedure was followed by incubation with horseradish peroxidase-conjugated secondary antibody (1:10,000, Santa Cruz Biotechnology) at room temperature for 3 h. Blots were developed by enhanced chemiluminescence (ECL) (Thermo Fisher Scientific) and the band intensities were quantified by ImageJ 219 (NIH). GAPDH (1:30,000, Sigma, St. Louis, MO) was used as an internal reference. The results were normalized for the control group (Saline-Saline) densitometry values and expressed as the relative amount of phosphorylated PKA (phosphor-PKA) and non-phosphorylated PKA (total-PKA) forms, and the phosphorylated/total ratio.
Statistical analyses
Data were analyzed by one-or two-way analysis of variance (ANOVA) depending on the experimental design. Post hoc analyses were carried out by the Student-Newman-Keuls test, when indicated. A p < 0.05 was considered significant.
Experimental groups 2.8.1. Experiment 1
This experiment was designed to investigate the effect of intrahippocampal (i.h.) SPD infusion on the persistence of contextual fear memory. Animals were trained in the fear conditioning apparatus, as described above. Twelve hours post-training the animals received an i.h. infusion of vehicle (saline) or SPD (0.02-2 nmol/site), and two or seven days after training were tested in the fear conditioning apparatus, as described above. The doses used in the current experiment are similar to those used in other studies (Berlese et al., 2005; Girardi et al., 2015; Gomes et al., 2010; Guerra et al., 2011 Guerra et al., , 2012 Rubin et al., 2000) . Doses of SPD around 200 nmol are toxic (Conway, 1998) .
Experiment 2
This experiment was designed to investigate the effect of i.h. arcaine infusion on the persistence of contextual fear memory. Animals were trained in the fear conditioning apparatus, as described above. Twelve hours post-training the animals received an i.h. infusion of vehicle (saline) or arcaine (0.02-2 nmol/site) and two or seven days after training were tested in the fear conditioning apparatus, as described above.
Experiment 3
This experiment was designed to investigate the involvement of polyamine-binding sites at the NMDA receptor in the facilitatory effect of SPD on the persistence of contextual fear memory. The animals were trained in the fear conditioning apparatus and 11:30 h post-training the animals received an ih infusion of vehicle (saline) or of the polyaminergic antagonist arcaine (at doses that have no effect per se on memory, 0.2 nmol/site). Twelve hours after training the animals received an i.h. infusion of vehicle (saline) or SPD (2 nmol/site). Seven days after training the animals were tested in the fear conditioning apparatus and their freezing responses were scored, as described above.
Experiment 4
This experiment was designed to investigate the involvement of protein synthesis in the effect of SPD on the persistence of memory. Animals were trained in the fear conditioning apparatus, as described above. Twelve hours post-training the animals received an i.h. infusion of vehicle (saline) or anisomycin (2-20 lg/site) and, seven days after training were tested in the fear conditioning apparatus, as described above.
Once determined that anisomycin at a dose of 2 lg/site did not alter the persistence of memory, the effect of anisomycin on SPDinduced improvement of the persistence memory was determined. The animals were trained in the fear conditioning apparatus. Eleven hours and 30 min post-training the animals received an i.h.
infusion of vehicle (saline) or anisomycin (2 lg/site) and 12 h after training the animals received an i.h. infusion of vehicle (saline) or SPD (2 nmol/site). Seven days after training the animals were tested in the fear conditioning apparatus and their freezing responses were scored, as described above.
Experiment 5
This experiment was designed to investigate the effect of i.h. infusion of the PKA inhibitor, H-89, on the persistence of memory as well as the involvement of PKA in the effect of SPD on the persistence of memory. Animals were trained in the contextual fear conditioning apparatus as described above. Twelve hours posttraining the animals received an i.h. infusion of vehicle (saline) or H-89 (0.5-10 pmol/site) and seven days after training were tested in the fear conditioning apparatus.
Once determined that H-89 does not alter the persistence of memory, the effect of H-89 on SPD-induced improvement of the persistence memory was determined. The animals were trained in the fear conditioning apparatus. Eleven hours and 30 min post-training the animals received an i.h. infusion of vehicle (saline) or H-89 (5 pmol/site) and 12 h after training the animals received an i.h. infusion of vehicle (saline) or SPD (2 nmol/site). Seven days after training the animals were tested in the fear conditioning apparatus and their freezing responses were scored, as described above.
Experiment 6
This experiment was designed to investigate the effect of i.h. infusion of H-89 on SPD-induced phosphorylation of PKA. The animals were trained in the fear conditioning apparatus. Eleven hours and 30 min post-training the animals received an i.h. infusion of vehicle (saline) or H-89 (5 pmol/site) and 12 h after training the animals received an i.h. infusion of vehicle (saline) or SPD (2 nmol/site). Three hours after the infusion of SPD the animals were sacrificed and the hippocampi were dissected for Western blot analysis of PKA.
Results
Fig . 1A and B shows the effect of bilateral i.h. infusion of SPD (0.02-2 nmol/site, 12 h post-training) on the memory of fear assessed 2 or 7 days after training, respectively. Statistical analysis (one-way ANOVA) revealed that SPD did not alter the freezing scores of animals tested at 2 days (Fig. 1A) . On the other hand, 2 nmol of SPD increased the freezing scores of animals tested at 7 days [F(3, 16) = 7.72, p < 0.05, Fig. 1B] . Fig. 2A and B shows the effect of bilateral i.h. infusion of arcaine (0.02-2 nmol/site, 12 h post-training) on the memory of fear assessed 2 or 7 days after training, respectively. Statistical analysis (one-way ANOVA) revealed that arcaine did not alter the freezing scores of animals tested at 2 days ( Fig. 2A) . On the other hand, 2 nmol of arcaine decreased the freezing scores of animals tested at 7 days [F(3, 14) = 8.21, p < 0.05, Fig. 2B ]. Fig. 3 shows the effect of arcaine, at the dose that had no effect per se (0.2 nmol), on SPD-induced improvement of the memory of fear assessed 7 days after training. Statistical analysis (two-way ANOVA) revealed a significant pretreatment (saline or arcaine) versus treatment (saline or SPD) interaction [F(1, 15) = 20.48, p < 0.05], suggesting that the facilitatory effect of SPD may involve the NMDA receptor. (Fig. 6A ) and total-PKA immunoreactivity (Fig. 6B) . However, we showed a significant pretreatment (saline or H-89) versus treatment (saline or SPD) interaction for phospho-PKA/total-PKA ratio [F(1, 32) = 7.33, p < 0.05, Fig. 6C ]. This result suggests that H-89 prevents the SPD-induced increase in the phospho-PKA/total-PKA ratio.
Discussion
The current study showed that while a 12 h after training i.h. infusion of SPD improves (Fig. 1B) , the infusion of the antagonist of the polyamine binding site at the NMDA receptor arcaine impairs (Fig. 2B ) the persistence of the memory of contextual fear conditioning, assessed 7 days after training. We also showed that i. h. infusion of arcaine prevents, at doses that have no effect on memory per se, the facilitatory effect of SPD (Fig. 3) . These results are in agreement with a recent study that showed that systemic administration of SPD and arcaine 12 h after training respectively improves and impairs the persistence of the memory of contextual fear conditioning task (Signor et al., 2014) . Moreover, they collectively provide convincing pharmacological evidence for a role for hippocampal polyamines in the persistence of contextual fear conditioning, as far as agonists and antagonists of the polyaminergic binding site at the NMDA receptor have opposite effects, and the effect of the agonist is prevented by the antagonist. Due to this pharmacological profile, we suggest that the facilitatory effect of SPD may involve GluN2B receptors, and that endogenous polyamines may play a role in memory persistence. However, our experimental data does not allow us determining whether the effects of SPD involve glial cells or other targets. For instance, the biphasic effect of SPD on memory can also be explained by the interaction with alternative targets for polyamines, such as TRPV1 receptors, which blockade impairs memory (Genro, de Oliveira, & Quillfeldt, 2012) . In addition, it is possible that injected natural polyamines enter into neurons (and possibly glial cells) through NMDA receptors and by these means directly modulate intracellular mechanisms. In fact, NMDAr-driven polyamine influx was shown in outside-out patches from hippocampal neurons (Araneda, Lan, Zheng, Zukin, & Bennett, 1999) , Xenopus oocytes (Araneda et al., 1999; Hirose et al., 2015) and HEK-293 cells (Hirose et al., 2015) . Moreover, polyamines have also been reported to permeate GluK2 (Bähring, Bowie, Benveniste, & Mayer, 1997) in HEK-293 cells and TRPV1 receptors (Ahern, Wang, & Miyares, 2006) in Xenopus oocytes. Therefore, a direct intracellular modulation of the PKA pathway by injected SPD cannot be ruled out by our experimental data.
This study also showed that anisomycin infusion 12 h after training impairs the persistence of memory of contextual fear conditioning assessed 7 days after training (Fig. 4A) and prevents the facilitatory effect of SPD (Fig. 4B) . The finding that anisomycin impairs memory persistence confirms data of Bekinschtein et al. (2007) , who have shown that anisomycin infusion 12 h but not 9 or 24 h after training blocks late consolidation. These findings are also consistent with the view that the inhibition of protein synthesis in the dorsal hippocampus around 12 h after training is strictly related to the maintenance, but not the formation of the memory trace. However, Katche et al. (2010) have reported that the protein synthesis inhibitor a-amanitine impairs memory persistence when it is infused into the hippocampus 24 h, but not 12 h after training. Moreover, it has been shown that anisomycin can have other important effects on neurobiological function including induction of immediate early genes (Edwards & Mahadevan, 1992; Gold, 2007; Radulovic & Tronson, 2008; Rudy, Biedenkapp, Moineau, & Bolding, 2006) alterations in synaptic release (Canal, Chang, & Gold, 2007) and profound suppression of neural activity (Greenberg, Ward-Flanagan, Dickson, & Treit, 2014; Sharma, Nargang, & Dickson, 2012) . Therefore, we cannot rule out that other effects of anisomycin, unrelated to protein synthesis inhibition, have interfered in the spermidine-induced improvement of memory persistence. In this regard, administration of SPD protects from age-induced memory impairment in an autophagydependent manner in Drosophila (Gupta et al., 2013) . As anisomycin inhibits autophagy (Finn, Mesires, Vine, & Dice, 2005) and prevented SPD-induced increase persistence of memory, we cannot rule out a role for autophagy in this effect. On the other hand, autophagy does not seem to explain the preventing effect of H-89 on SPD-induced improvement of memory persistence because both SPD and H-89 induce autophagy (Inoue, Hase, Segawa, & Takita, 2013) . At last, since these interesting studies were carried out in Drosophila or neuroblastoma cells, more studies are necessary to define a role for autophagy in SPD-induced improvement of memory in mammals.
It has been reported that persistence of contextual fear conditioning depends on the integrity of a protein kinase and cAMP oscillations for at least 1 week post-training (Eckel-Mahan et al., 2008) . In fact, PKA seems to be required for establishing late consolidation of fear learning, since the i.h. infusion of PKA inhibitors 12 h after training disrupt memory persistence (Chai et al., 2014; Rossato et al., 2009) . Accordingly, the infusion of PKI 12 h after training impairs the persistence of inhibitory avoidance memory (Rossato et al., 2009 ) and the infusion of Rp-AMPS prevents, at doses that have no effect on memory per se, the facilitatory effect of norepinephrine (NE) on persistence of extinguished fear and NE-induced increase of phospho-PKA levels (Chai et al., 2014) . Interestingly, this study showed that the PKA inhibitor H-89 prevents the facilitatory effect of SPD on fear memory persistence ( Fig. 5B) , and to our knowledge, this is the first experimental evidence for a role of hippocampal PKA in the persistence of conditioned fear memory. In summary, this study provides experimental evidence for a role of hippocampal polyamines in the persistence of memory of contextual fear conditioning. Activation of GluN2B receptors, PKA and protein synthesis seem to underlie the improvement of memory persistence induced by SPD.
